<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02851758</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00014558</org_study_id>
    <nct_id>NCT02851758</nct_id>
  </id_info>
  <brief_title>Transplantation of Autologously Derived Mitochondria Following Ischemia</brief_title>
  <official_title>Transplantation of Autologously Derived Mitochondria for Protection Against Ischemia-reperfusion Injury Following Ischemia in Subjects on ECMO Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a robust therapeutic intervention to ameliorate myocardial
      ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients
      requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic
      mitochondria into the ischemic myocardium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Skeletal muscle biopsies will be collected during the subject's clinically indicated
      operative procedure. The removal of these biopsy specimens does not extend operative time or
      require alteration of normal surgical procedures or approach. These samples will then be
      processed for mitochondria abstraction. Prior studies demonstrate that the number of
      mitochondria obtained from the same size biopsy provides approximately 1 x 10^10 viable
      mitochondria. Autologous mitochondria (4 x 10^7/mL) are transplanted epicardially using a 1
      mL insulin syringe with a 28 gage needle to the damaged area via 5-10 injections. Total
      injection volume is roughly 0.8 mL (3.2 x 10^7 mitochondria).

      Therapy will be delivered at bedside in the CICU during open chest procedure or in the
      cardiac OR during re-operative procedure. A portable hood will be brought to bedside to
      isolate mitochondria. All equipment and solutions will be medical grade.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety- Incidence of severe adverse events</measure>
    <time_frame>1 week</time_frame>
    <description>Subjects will be SAE free for one week following injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy- Improvement in Outcome measures: increased ventricular function on echocardiogram, measured by ejection fraction</measure>
    <time_frame>1 week- 1 month</time_frame>
    <description>Improvement in ventricular function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy- Improvement in Outcome measures: ability to be separated from ECMO support, measured in days since injection</measure>
    <time_frame>1 week- 1 month</time_frame>
    <description>The ability to decannulate from ECMO support</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Extracorporeal Membrane Oxygenation Complication</condition>
  <arm_group>
    <arm_group_label>Autologous mitochondria injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will have autologous mitochondria injected into ischemic areas of the myocardium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>autologous mitochondria transplantation</intervention_name>
    <description>Autologous mitochondria obtained from the subject's own skeletal muscle will be injected into the ischemic myocardium</description>
    <arm_group_label>Autologous mitochondria injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric cardiology patients under the age of 18 on ECMO

          -  concerns for ischemic injury on the Cardiac Intensive Care Unit

        Exclusion Criteria:

          -  Known mitochondria disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sitaram M Emani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Breanna Piekarski, RN, BSN</last_name>
    <phone>617-919-4457</phone>
    <email>breanna.piekarski@cardio.chboston.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Breanna Piekarski, RN, BSN</last_name>
      <phone>617-919-4457</phone>
      <email>breanna.piekarski@cardio.chboston.org</email>
    </contact>
    <investigator>
      <last_name>Sitaram M Emani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Sitaram Emani</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

